|
FKBP14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.636860E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.227180E-04 |
| Normal-vs-Stage2 |
3.700400E-03 |
| Normal-vs-Stage3 |
4.439900E-02 |
| Normal-vs-Stage4 |
3.386400E-02 |
| Stage1-vs-Stage2 |
9.924400E-01 |
| Stage1-vs-Stage3 |
3.410000E-01 |
| Stage1-vs-Stage4 |
6.675400E-01 |
| Stage2-vs-Stage3 |
4.423400E-01 |
| Stage2-vs-Stage4 |
7.130000E-01 |
| Stage3-vs-Stage4 |
7.692200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.462410E-03 |
| Normal-vs-AfricanAmerican |
3.393400E-01 |
| Normal-vs-Asian |
9.203700E-03 |
| Caucasian-vs-AfricanAmerican |
3.468400E-01 |
| Caucasian-vs-Asian |
8.412600E-01 |
| AfricanAmerican-vs-Asian |
3.273400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.243040E-03 |
| Normal-vs-Female |
3.203600E-03 |
| Male-vs-Female |
4.692000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.760600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.281760E-03 |
| Normal-vs-Age(61-80Yrs) |
1.862200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.528200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.955200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.279200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.527400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.054400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.058600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.679800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.200600E-01 |
| Classical-VS-Follicular |
5.935700E-02 |
| Classical-VS-Other |
1.701640E-01 |
| Classical-VS-Normal |
1.456400E-02 |
| Tall-VS-Follicular |
7.841200E-01 |
| Tall-VS-Other |
2.922200E-01 |
| Tall-VS-Normal |
4.526500E-02 |
| Follicular-VS-Other |
3.942600E-01 |
| Follicular-VS-Normal |
1.780380E-04 |
| Other-VS-Normal |
9.460700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.48079999999318E-05 |
| Normal-vs-N1 |
3.173600E-02 |
| N0-vs-N1 |
4.870800E-01 |
|
|
